1. 您所在位置：
  2. 网站首页
  3. 文档分类
  4. 医药卫生
  5. 药学

靶向EGFR与MET双特异性抗体药物说明书概要.pdfVIP

  • 0
  • 0
  • 约11.92万字
  • 约 23页
  • 2026-01-04 发布于北京
  • 举报

靶向EGFR与MET双特异性抗体药物说明书概要.pdf

    CONTRAINDICATIONS

    HIGHLIGHTSOFPRESCRIBINGINFORMATION

    None.(4)

    Thesehighlightsdonotincludealltheinformationneededtouse

    RYBREVANT™safelyandeffectively.SeefullprescribinginformationWARNINGSANDPRECAUTIONS

    forRYBREVANT.•Infusion-RelatedReactions(IRR):Interruptinfusionatthefirstsignof

    IRRs.ReduceinfusionrateorpermanentlydiscontinueRYBREVANT

    RYBREVANT(amivantamab-vmjw)injection,forintravenoususebasedonseverity.(2.4,5.1)

    InitialU.S.Approval:2021•InterstitialLungDisease(ILD)/Pneumonitis:Monitorforneworworsening

    symptomsindicativeofILD.ImmediatelywithholdRYBREVANTin

    INDICATIONSANDUSAGEpatientswithsuspectedILD/pneumonitisandpermanentlydiscontinueif

    RYBREVANTisabispecificEGFreceptor-directedandMETreceptor-ILD/pneumonitisisconfirmed.(2.4,5.2)

    directedantibodyindicatedforthetreatmentofadultpatientswithlocally•DermatologicAdverseReactions:Maycauserashincludingacneiform

    advancedormetastaticnon-smallcelllungcancer(NSCLC)withepidermal

    您可能关注的文档

    最近下载

    文档评论（0）

    1亿VIP精品文档

    更多 >

    相关文档

    更多 >